Candesic acts as Adviser to Australia’s Citadel Group on its acquisition of UK-based Wellbeing Software for £103m
18 February 2020Candesic is proud to announce our role as Adviser to Australia's The Citadel Group on its acquisition of Wellbeing Software,…Candesic acts as Adviser to Gulf Capital on its US$40M investment in Vezeeta
11 February 2020Candesic is pleased to announce our role as Adviser to Gulf Capital on its US$40M investment in Vezeeta.com, the Middle…Candesic acts as Adviser to Gulf Capital on its US$100m acquisition of IVI-RMA’s Middle Eastern IVF fertility operation
14 January 2020Candesic acts as Adviser to Gulf Capital on its US$100m acquisition of IVI-RMA's Middle Eastern IVF fertility operation.Special housing portfolio advisor
6 August 2019Candesic advised a real estate investor on the development of a major property company with Résidence Mobicap in France. The project undertakes…Waterland Private Equity investing in Irish nursing home provider
31 July 2019Candesic worked alongside Waterland Private Equity as they invested in Silver Stream Healthcare Group. Silver Stream is one of the largest…Charleston Holding GMbH sold to KOS Group by EQT
31 July 2019Congratulations to our client KOS GROUP on the acquisition of Charleston Holding GmbH, one of the top-10 nursing home providers…Vespa Capital invests in Bluecrest Health
25 July 2019Candesic is proud to have provided the commercial due diligence and strategic guidance that resulted in the 17M GBP investment…ArchiMed acquires Eurolyser Diagnostica
17 July 2019Congratulations to our client ArchiMed on their acquisition of Eurolyser Diagnostica, a fast-growing Austrian IVD player. The announcement follows ArchiMed's…Candesic supports the $450m sale of Blue Earth Diagnostics to Bracco Group
28 June 2019Congratulations to Blue Earth Diagnostics' CEO Jonathan Allis and the management team on this $450M deal. Candesic is proud to…Tikehau invests in Medtrade
13 May 2019Tikehau Capital, through its pan-European growth equity fund, is investing £23m (c. €26m) in Medtrade Products Limited, the UK-based technology-led…